This website uses cookies to enhance your experience.

Improve your workflow with our solutions

ANALIS SOLUTIONS FOR YOUR WORKFLOW

Providing solutions tailored to laboratory needs requires a good understanding of the workflows. 

The expertise and multidisciplinary skills of Analis employees associated with the complete solutions offered make it possible to face the major challenges of tomorrow, whether they are scientific, technological, environmental or societal. These available resources condition success and help accelerate innovation within these cutting-edge research laboratories and technological platforms. We invite you to regularly consult this page, the content of which will gradually expand over time.
 
 

Cell & Gene Therapies (CGTs)

Recent years have seen a steady acceleration in the number of cell and gene therapies (CGTs) on the market. More than 75 had been launched by the end of 2019. Many more are in development, offering the hope of revolutionary healthcare (see more in 2021  McKinsey & Cie article).   A broad overview of adapted solutions to address cell & gene therapies laboratories needs are illustrated in the steps of our immunotherapy workflow illustrating CAR-T cells :

IMMUNOTHERAPY

In the last few decades new immunotherapy treatments are being tested and approved, and new ways of working with the immune system are being discovered at a very fast pace. Immunotherapies include cell-based therapies, antibody-based therapies, vaccines, and combination therapies including gene therapies.
Discover through the immunotherapy workflow how the solutions offered by Analis can help you meet your main challenges of early discovery or scaling-up the production process.

SYNTHETIC BIOLOGY (Synbio)

Synthetic Biology is bringing together engineers and biologists to design or redesign and build novel biomolecular components, networks and pathways, and to use these constructs to rewire and reprogram organisms. It enables life technologies to design, synthesize, test and deploy antigens and variants with rapid results, high expression and capacity. In parallel to all other broad application, using synthetic genes is now a possibility to accelerate rapid vaccine development. Analis's broad portfolio offers efficient solutions to ACCELERATE  your SynBio workflow.
MOLECULAR DIAGNOSTICS
With regard to infectious disease, molecular diagnostics has major advantages over the sole use of serology. Molecular diagnostics is a more sensitive method allowing detection of lower amounts of infectious agents and therefore giving the ability to detect infections earlier than was previously possible.
The solutions offered by Analis support you both in the molecular diagnostic workflows of viral and bacterial pathogens, but also with strong solutions to support your clinical research in oncology
 
 
COVID-19
Analis offers dedicated solutions to meet your specific needs regarding:
PROTECTION - PREVENTION – DISINFECTION – DIAGNOSIS & DETECTION – VIRUS CHARACTERIZATION - VACCINE DEVELOPMENT – VACCINE PRODUCTION
Don't hesitate to contact our experts.
 
 
 
 
 
 
 
Loading
Loading